Rachel E. Haurwitz - Net Worth and Insider Trading

Rachel E. Haurwitz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rachel E. Haurwitz owns 3 companies in total, including Intellia Therapeutics Inc (NTLA) , Caribou Biosciences Inc (CRBU) , and Seer Inc (SEER) .

Click here to see the complete history of Rachel E. Haurwitz’s form 4 insider trades.

Insider Ownership Summary of Rachel E. Haurwitz

Ticker	Comapny	Transaction Date	Type of Owner
NTLA	Intellia Therapeutics Inc	2016-05-05	director & 10 percent owner
CRBU	Caribou Biosciences Inc	2021-07-22	director & See Remarks
SEER	Seer Inc	2021-11-08	director

Rachel E. Haurwitz Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Rachel E. Haurwitz Ownership Network

Ownership Network List of Rachel E. Haurwitz

No Data

Ownership Network Relation of Rachel E. Haurwitz

Rachel E. Haurwitz Owned Company Details

What does Intellia Therapeutics Inc do?

Who are the key executives at Intellia Therapeutics Inc?

Rachel E. Haurwitz is the director & 10 percent owner of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Scientific Officer Laura Sepp-lorenzino , EVP & Chief Business Officer Derek Hicks , and EVP & Chief Technical Officer Eliana Clark .

Intellia Therapeutics Inc (NTLA) Insider Trades Summary

Over the past 18 months, Rachel E. Haurwitz made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 11,996 shares made by Eliana Clark , a net sale of 12,645 shares made by Laura Sepp-lorenzino , and a net sale of 2,397 shares made by Muna Bhanji .

In summary, during the past 3 months, insiders sold 0 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 79,775 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 79,775 shares.

Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Intellia Therapeutics Inc Insider Transactions

No Available Data

What does Caribou Biosciences Inc do?

Who are the key executives at Caribou Biosciences Inc?

Rachel E. Haurwitz is the director & See Remarks of Caribou Biosciences Inc. Other key executives at Caribou Biosciences Inc include Chief Medical Officer Syed Ali-aamir Rizvi , See Remarks Ryan Fischesser , and See Remarks Steven Kanner .

Caribou Biosciences Inc (CRBU) Insider Trades Summary

Over the past 18 months, Rachel E. Haurwitz made no insider transaction in Caribou Biosciences Inc (CRBU). Other recent insider transactions involving Caribou Biosciences Inc (CRBU) include a net sale of 5,627 shares made by Syed Ali-aamir Rizvi ,

In summary, during the past 3 months, insiders sold 0 shares of Caribou Biosciences Inc (CRBU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,627 shares of Caribou Biosciences Inc (CRBU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,627 shares.

Caribou Biosciences Inc (CRBU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Caribou Biosciences Inc Insider Transactions

No Available Data

What does Seer Inc do?

Who are the key executives at Seer Inc?

Rachel E. Haurwitz is the director of Seer Inc. Other key executives at Seer Inc include director & 10 percent owner & CEO and Chair of the Board Omid Farokhzad , Chief Financial Officer David R. Horn , and General Counsel and Secretary Elona Esq. Kogan .

Seer Inc (SEER) Insider Trades Summary

Over the past 18 months, Rachel E. Haurwitz made no insider transaction in Seer Inc (SEER). Other recent insider transactions involving Seer Inc (SEER) include a net sale of 46,853 shares made by David R. Horn , a net sale of 44,676 shares made by Omid Farokhzad , and a net sale of 26,817 shares made by Elona Esq. Kogan .

In summary, during the past 3 months, insiders sold 81,833 shares of Seer Inc (SEER) in total and bought 0 shares, with a net sale of 81,833 shares. During the past 18 months, 159,814 shares of Seer Inc (SEER) were sold and 40,000 shares were bought by its insiders, resulting in a net sale of 119,814 shares.

Seer Inc (SEER)'s detailed insider trading history can be found in Insider Trading Tracker table.

Seer Inc Insider Transactions

No Available Data

Rachel E. Haurwitz Mailing Address

Above is the net worth, insider trading, and ownership report for Rachel E. Haurwitz. You might contact Rachel E. Haurwitz via mailing address: C/o Caribou Biosciences, Inc., 2929 7th Street, Suite 105, Berkeley Ca 94710.

Discussions on Rachel E. Haurwitz

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.